PROCESS 10TH EDITION TEST BANK
QUESTIONS & ANSWERS
Placebo - ANS-Incorporated into drug studies to prevent bias from unrealistic expectations of new drug's
usefulness.
Phase I - ANS-Study type involving healthy volunteers to determine optimal drug dosage and
pharmacokinetics.
Schedule C-III - ANS-Allows analgesic refills no more than five times in a 6-month period.
Informed consent - ANS-Involves explaining study purpose, procedures, and risks to the patient.
Native Americans - ANS-Believe in preserving harmony with nature and illness caused by ill spirits.
Cultural assessment - ANS-Includes gathering information about religious practices, beliefs, and rituals.
Schedule II drugs - ANS-High potential for abuse but have accepted medical use.
Legend drug - ANS-Refers to prescription drugs, differentiated from over-the-counter drugs.
Beneficence - ANS-Ethical responsibility of doing or actively promoting good.
Autonomy - ANS-Includes self-determination and ability to make own decisions.
Medication error - ANS-Preventable adverse drug event involving inappropriate medication use.
Levothyroxine - ANS-Correct notation: 0.75 mg with a leading zero before the decimal point.
Near-miss - ANS-Requires reporting using facility's recommended protocol, regardless of whether an
error occurred.
Dosing errors - ANS-Most common medication errors in pediatrics.
Drug polymorphism - ANS-Factors contributing: inherited factors, diet and nutritional status, and
cultural practices.